Matches in SemOpenAlex for { <https://semopenalex.org/work/W2746644955> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2746644955 endingPage "3997" @default.
- W2746644955 startingPage "3997" @default.
- W2746644955 abstract "Background: Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. Among the pharmacological therapy, inhaled beta- agonist and anticholinergics are the mainstay therapy of COPD along with corticosteroid. Steroid therapy is associated with various potential adverse effects like steroid induced deranged glycemic status. So, we sought to examine the association between long term corticosteroid therapy and glycemic status in COPD patients.Methods: A cross sectional study was done to assess the glycemic status in COPD patients on long term corticosteroid therapy in a rural tertiary care centre on patients satisfying inclusion and exclusion criteria. Inclusion criteria includes COPD patients on steroid based therapy (inhaled/systemic or both) for at least 6 months. Known case of type 2 diabetes mellitus, bronchial asthma, interstitial lung disease, coronary artery disease, cardiomyopathies, connective tissue disorders, recipients of organ transplant or immunosuppressive therapy, patients having co morbidities like renal failure, liver failure, heart failure and patients on other drugs known to cause hyperglycemia were excluded. Random blood sugar, HbA1C etc, was done and data was analyzed by SPSS version 22.0.Results: Total 46 patients were included in study. Mean age was 63.22 years with minimum age 47 years and maximum age 80 years. 35 patients (76.09%) were male and 11 patients (23.91%) were female. Sex ratio was 3.18:1. 26 patients (56.52%) were taking both inhaled and systemic corticosteroids, 12 patients (26.09%) were taking only inhaled corticosteroids and 8 patients (17.39%) were taking systemic corticosteroid therapy. 14 patients (30.43%) were found to have impaired glucose tolerance, 7 patients (15.22%) were diagnosed as a case of diabetes mellitus and 25 patients (54.35%) were found to be euglycemic.Conclusions: We conclude that incidence of deranged glycemic status is more common among COPD patients receiving only systemic corticosteroid therapy or both systemic and inhaled corticosteroid therapy. Further, inhaled corticosteroids are better in terms of glycemic control among COPD patients on corticosteroid therapy. Hence, we recommend routine screening of glycemic status in COPD patients on corticosteroid therapy." @default.
- W2746644955 created "2017-08-31" @default.
- W2746644955 creator A5003658917 @default.
- W2746644955 creator A5039258247 @default.
- W2746644955 creator A5046036725 @default.
- W2746644955 creator A5046900975 @default.
- W2746644955 creator A5062052137 @default.
- W2746644955 creator A5078725383 @default.
- W2746644955 date "2017-08-26" @default.
- W2746644955 modified "2023-10-18" @default.
- W2746644955 title "Assessment of glycemic status of COPD patients on long term corticosteroid therapy" @default.
- W2746644955 doi "https://doi.org/10.18203/2320-6012.ijrms20173970" @default.
- W2746644955 hasPublicationYear "2017" @default.
- W2746644955 type Work @default.
- W2746644955 sameAs 2746644955 @default.
- W2746644955 citedByCount "1" @default.
- W2746644955 countsByYear W27466449552019 @default.
- W2746644955 crossrefType "journal-article" @default.
- W2746644955 hasAuthorship W2746644955A5003658917 @default.
- W2746644955 hasAuthorship W2746644955A5039258247 @default.
- W2746644955 hasAuthorship W2746644955A5046036725 @default.
- W2746644955 hasAuthorship W2746644955A5046900975 @default.
- W2746644955 hasAuthorship W2746644955A5062052137 @default.
- W2746644955 hasAuthorship W2746644955A5078725383 @default.
- W2746644955 hasBestOaLocation W27466449551 @default.
- W2746644955 hasConcept C126322002 @default.
- W2746644955 hasConcept C134018914 @default.
- W2746644955 hasConcept C197934379 @default.
- W2746644955 hasConcept C2776042228 @default.
- W2746644955 hasConcept C2776780178 @default.
- W2746644955 hasConcept C2777104659 @default.
- W2746644955 hasConcept C2779306644 @default.
- W2746644955 hasConcept C2780473172 @default.
- W2746644955 hasConcept C555293320 @default.
- W2746644955 hasConcept C71924100 @default.
- W2746644955 hasConceptScore W2746644955C126322002 @default.
- W2746644955 hasConceptScore W2746644955C134018914 @default.
- W2746644955 hasConceptScore W2746644955C197934379 @default.
- W2746644955 hasConceptScore W2746644955C2776042228 @default.
- W2746644955 hasConceptScore W2746644955C2776780178 @default.
- W2746644955 hasConceptScore W2746644955C2777104659 @default.
- W2746644955 hasConceptScore W2746644955C2779306644 @default.
- W2746644955 hasConceptScore W2746644955C2780473172 @default.
- W2746644955 hasConceptScore W2746644955C555293320 @default.
- W2746644955 hasConceptScore W2746644955C71924100 @default.
- W2746644955 hasIssue "9" @default.
- W2746644955 hasLocation W27466449551 @default.
- W2746644955 hasOpenAccess W2746644955 @default.
- W2746644955 hasPrimaryLocation W27466449551 @default.
- W2746644955 hasRelatedWork W1655255453 @default.
- W2746644955 hasRelatedWork W2164992420 @default.
- W2746644955 hasRelatedWork W2333559685 @default.
- W2746644955 hasRelatedWork W2413421841 @default.
- W2746644955 hasRelatedWork W2614485339 @default.
- W2746644955 hasRelatedWork W2905407489 @default.
- W2746644955 hasRelatedWork W3028702831 @default.
- W2746644955 hasRelatedWork W3214905250 @default.
- W2746644955 hasRelatedWork W4229044281 @default.
- W2746644955 hasRelatedWork W4255825817 @default.
- W2746644955 hasVolume "5" @default.
- W2746644955 isParatext "false" @default.
- W2746644955 isRetracted "false" @default.
- W2746644955 magId "2746644955" @default.
- W2746644955 workType "article" @default.